Oxygenta Pharma - Quaterly Results

20 May 2022 Evaluate
The sales moved down -36.21% to Rs. 70.76 millions for the March 2022 quarter as compared to Rs. 110.92 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -9.13 millions as compared to Net Profit of Rs. 8.08 millions of corresponding quarter ended March 2021Operating profit Margin for the quarter ended March 2022 slipped to -14.30% as compared to 5.87% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 70.76 110.92 -36.21 605.25 520.27 16.33 605.25 520.27 16.33
Other Income 0.03 0.68 -95.59 0.05 0.91 -94.51 0.05 0.91 -94.51
PBIDT -14.30 5.87 -343.61 14.81 39.34 -62.35 14.81 39.34 -62.35
Interest 1.64 13.25 -87.62 9.25 17.83 -48.12 9.25 17.83 -48.12
PBDT -4.10 14.51 -128.26 11.02 43.40 -74.61 11.02 43.40 -74.61
Depreciation 3.82 4.29 -10.96 15.91 11.96 33.03 15.91 11.96 33.03
PBT -7.92 10.22 -177.50 -4.89 31.44 -115.55 -4.89 31.44 -115.55
TAX 1.21 2.14 -43.46 1.21 2.14 -43.46 1.21 2.14 -43.46
Deferred Tax 1.21 2.14 -43.46 1.21 2.14 -43.46 1.21 2.14 -43.46
PAT -9.13 8.08 -213.00 -6.10 29.30 -120.82 -6.10 29.30 -120.82
Equity 142.01 102.01 39.21 142.01 102.01 39.21 142.01 102.01 39.21
PBIDTM(%) -20.21 5.29 -481.87 2.45 7.56 -67.64 2.45 7.56 -67.64

Oxygenta Pharma Share Price

98.26 0.00 (0.00%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.